about
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining f...
Read More
17.65
-0.05
(-0.28%)
11.4M
XNAS Volume
XNAS 05 Aug, 2026 5:30 PM (EDT)
Low Financial Strength
Mid Valuation
Technically Moderately Bullish
Momentum Trap
These stocks have average financials but are currently seeing momentum. Investors should exercise caution in buying these stocks
View Similar
Embed DVM
Viatris Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..